Tuberculous meningitis: More questions, still too few answers

The Lancet Neurology

Volumn 12, Issue 10, 2013, Pages 999-1010

  Thwaites, Guy E ^a,b   van Toorn, Ronald ^c   Schoeman, Johan ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BCG VACCINE; CHLOROQUINE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; FUROSEMIDE; GAMMA INTERFERON; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THALIDOMIDE; TUBERCULOSTATIC AGENT;

ABSCESS; ADAPTIVE IMMUNITY; ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; BCG VACCINATION; CEREBROSPINAL FLUID PRESSURE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMMUNICATING HYDROCEPHALUS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; INTRACRANIAL TUBERCULOMA; LABORATORY DIAGNOSIS; MICROSCOPY; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; OPTIC NEURITIS; PATHOGENESIS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS; VASCULITIS;

ADULT; CHILD; HUMANS; TUBERCULOSIS, MENINGEAL;

EID: 84884160998     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70168-6     Document Type: Review

References (135)

1. Thwaites GE, Hien TT Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005, 4:160-170.
2. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 2010, 10:67.
3. Zhang LX, Tu DH, Enarson DA The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing. Int J Tuberc Lung Dis 2000, 4:904-910.
4. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
5. Global tuberculosis control 2011 2011, WHO, World Health Organization, Geneva.
6. Abubakar I, Lipman M, Anderson C, Davies P, Zumla A Tuberculosis in the UK-time to regain control. BMJ 2011, 343:d4281.
7. Wolzak NK, Cooke ML, Orth H, van Toorn R The changing profile of pediatric meningitis at a referral centre in Cape Town, South Africa. J Trop Pediatr 2012, 58:491-495.
8. Trunz BB, Fine PEM, Dye C Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006, 367:1173-1180.
9. McShane H Tuberculosis vaccines: beyond bacille Calmette-Guérin. Philos Trans R Soc Lond B Biol Sci 2011, 366:2782-2789.
10. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control 2006, National Collaborating Centre for Chronic Conditions, Royal College of Physicians, London.
11. Rich AR, McCordock HA The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp 1933, 52:5-37.
12. Donald PR, Schaaf HS, Schoeman JF Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect 2005, 50:193-195.
13. Krishnan N, Robertson BD, Thwaites G The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2010, 90:361-366.
14. Hawn TR, Dunstan SJ, Thwaites GE, et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 2006, 194:1127-1134.
15. Thuong NT, Hawn TR, Thwaites GE, et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007, 8:422-428.
16. Ralph AP, Lucas RM, Norval M Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 2013, 13:77-88.
17. Visser DH, Schoeman JF, van Furth AM Seasonal variation in the incidence rate of tuberculous meningitis is associated with sunshine hours. Epidemiol Infect 2013, 141:459-462.
18. Caws M, Thwaites G, Dunstan S, et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008, 4:e1000034.
19. Krishnan N, Malaga W, Constant P, et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 2011, 6:e23870.
20. Jain SK, Paul-Satyaseela M, Lamichhane G, Kim KS, Bishai WR Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis 2006, 193:1287-1295.
21. Jain SK, Hernandez-Abanto SM, Cheng QJ, et al. Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice. J Infect Dis 2007, 195:1634-1642.
22. Be NA, Lamichhane G, Grosset J, et al. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. J Infect Dis 2008, 198:1520-1528.
23. Be NA, Bishai WR, Jain SK Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis. BMC Microbiol 2012, 12:7.
24. van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 2009, 123:e1-e8.
25. Lincoln EM, Sordillo SUR, Davies PA Tuberculous meningitis in children. J Pediatr 1960, 57:807-823.
26. Smith HV, Vollum RL The diagnosis of tuberculous meningitis. Br Med Bull 1954, 10:140-144.
27. Donald PR, Schoeman JF, van Schalkwyk HJ The 'Road to Health' card in tuberculous meningitis. J Trop Pediatr 1985, 31:117-120.
28. Smith HV Tuberculous meningitis. Int J Neurol 1964, 4:134-157.
29. Garg RK Tuberculosis of the central nervous system. Postgrad Med J 1999, 75:133-140.
30. Thwaites G, Caws M, Chau TT, et al. The relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol 2008, 46:1363-1368.
31. Maree F, Hesseling AC, Schaaf HS, et al. Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis. Pediatr Infect Dis J 2007, 26:13-18.
32. Seddon JA, Visser DH, Bartens M, et al. Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J 2012, 31:711-716.
33. Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005, 192:2134-2141.
34. van der Weert EM, Hartgers NM, Schaaf HS, et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2006, 25:65-69.
35. Kumar R, Dwivedi A, Kumar P, Kohli N Tuberculous meningitis in BCG vaccinated and unvaccinated children. J Neurol Neurosurg Psychiatry 2005, 76:1550-1554.
36. Wasay M, Ajmal S, Taqui AM, et al. Impact of bacille Calmette-Guérin vaccination on neuroradiological manifestations of pediatric tuberculous meningitis. J Child Neurol 2010, 25:581-586.
37. Kumar R, Singh SN, Kohli N A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999, 81:221-224.
38. Youssef FG, Afifi SA, Azab AM, et al. Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters. Diagn Microbiol Infect Dis 2006, 55:275-278.
39. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002, 360:1287-1292.
40. Hristea A, Olaru ID, Baicus C, Moroti R, Arama V, Ion M Clinical prediction rule for differentiating tuberculous from viral meningitis. Int J Tuberc Lung Dis 2012, 16:793-798.
41. Vibha D, Bhatia R, Prasad K, et al. Validation of diagnostic algorithm to differentiate between tuberculous meningitis and acute bacterial meningitis. Clin Neurol Neurosurg 2012, 114:639-644.
42. Cohen DB, Zijlstra EE, Mukaka M, et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health 2010, 15:910-917.
43. Patel VB, Singh R, Connolly C, et al. Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS One 2010, 5:e15664.
44. Sunbul M, Atilla A, Esen S, Eroglu C, Leblebicioglu H Thwaites' diagnostic scoring and the prediction of tuberculous meningitis. Med Princ Pract 2005, 14:151-154.
45. Török ME, Nghia HD, Chau TT, et al. Validation of a diagnostic algorithm for adult tuberculous meningitis. Am J Trop Med Hyg 2007, 77:555-559.
46. Checkley AM, Njalale Y, Scarborough M Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi. Trop Med Int Health 2008, 13:1042-1046.
47. Jackson A, van der Horst C New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep 2012, 9:267-277.
48. Stewart SM The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol 1953, 6:241-242.
49. Thwaites GE, Chau TT, Farrar JJ Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004, 42:378-379.
50. Chen P, Shi M, Feng GD, et al. A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M tuberculosis in cerebrospinal fluid. J Clin Microbiol 2012, 50:1166-1170.
51. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003, 3:633-643.
52. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009, 59:167-187.
53. Takahashi T, Nakayama T Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA. J Clin Microbiol 2006, 44:1029-1039.
54. Takahashi T, Tamura M, Asami Y, et al. Novel "wide range" quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA-development and methodology. J Clin Microbiol 2008, 46:1708-1715.
55. Haldar S, Sankhyan N, Sharma N, et al. Detection of Mycobacterium tuberculosis GlcB or HspX antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children. PLoS One 2012, 7:e44630.
56. Chaidir L, Ganiem AR, Vander Zanden A, et al. Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia. PLoS One 2012, 7:e52001.
57. Bhigjee AI, Padayachee R, Paruk H, Hallwirth-Pillay KD, Marais S, Connoly C Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 2007, 11:348-354.
58. Haldar S, Sharma N, Gupta VK, Tyagi JS Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR. J Med Microbiol 2009, 58:616-624.
59. Lawn SD, Nicol MP Xpert MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011, 6:1067-1082.
60. Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012, 64:580-588.
61. Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the GeneXpert MTB/RIF assay in a district hospital in India. Tuberc Res Treat 2012, 2012:932862.
62. Patel VB, Singh R, Connolly C, et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med 2010, 182:569-577.
63. Kim SH, Cho OH, Park SJ, et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis 2010, 50:1349-1358.
64. Vidhate MR, Singh MK, Garg RK, et al. Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis. J Infect 2011, 62:400-403.
65. Park KH, Cho OH, Lee EM, et al. T-cell-based assays on cerebrospinal fluid and PBMCs for rapid diagnosis of TB meningitis in non-HIV patients. Eur Respir J 2012, 39:768-770.
66. Tho DQ, Török ME, Yen NT, et al. Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis. Antimicrob Agents Chemother 2012, 56:3074-3079.
67. Padayatchi N, Bamber S, Dawood H, Bobat R Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J 2006, 25:147-150.
68. Thwaites GE, Lan NT, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005, 192:79-88.
69. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006, 355:1539-1550.
70. Caws M, Ha DT, Török E, et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS One 2007, 2:e1173.
71. Botha H, Ackerman C, Candy S, Carr JA, Griffith-Richards S, Bateman KJ Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis. PLoS One 2012, 7:e38982.
72. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 2004, 34:876-885.
73. van der Merwe DJ, Andronikou S, Van Toorn R, Pienaar M Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation. Childs Nerv Syst 2009, 25:949-954.
74. Janse van Rensburg P, Andronikou S, van Toorn R, Pienaar M Magnetic resonance imaging of miliary tuberculosis of the central nervous system in children with tuberculous meningitis. Pediatr Radiol 2008, 38:1306-1313.
75. Thwaites GE, Macmullen-Price J, Tran TH, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007, 6:230-236.
76. Kalita J, Prasad S, Maurya PK, Kumar S, Misra UK MR angiography in tuberculous meningitis. Acta Radiol 2012, 53:324-329.
77. Bernaerts A, Vanhoenacker FM, Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003, 13:1876-1890.
78. 1H-magnetic resonance spectroscopy. Eur J Pediatr 2011, 170:379-387.
79. Guidelines for national tuberculosis programmes on the management of tuberculosis in children 2006, WHO, World Health Organization, Geneva.
80. Treatment of tuberculosis guidelines 2010, WHO, World Health Organization, Geneva. 4th edn.
81. Donald PR, Schoeman JF, Van Zyl LE, De Villiers JN, Pretorius M, Springer P Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis 1998, 2:704-711.
82. Donald PR The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (Edinb) 2010, 90:375-392.
83. Ellard GA, Humphries MJ, Allen BW Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993, 148:650-655.
84. Holdiness MR Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet 1985, 10:532-534.
85. Kaojarern S, Supmonchai K, Phuapradit P, Mokkhavesa C, Krittiyanunt S Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther 1991, 49:6-12.
86. Donald PR, Maher D, Maritz JS, Qazi S Ethambutol dosage for the treatment of children: literature review and recommendations. Int J Tuberc Lung Dis 2006, 10:1318-1330.
87. Donald PR, Seifart HI Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr 1989, 115:483-486.
88. Thwaites GE, Bhavnani SM, Chau TT, et al. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother 2011, 55:3244-3253.
89. Alffenaar JW, van Altena R, Bokkerink HJ, et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis 2009, 49:1080-1082.
90. Mehlhorn AJ, Brown DA Safety concerns with fluoroquinolones. Ann Pharmacother 2007, 41:1859-1866.
91. Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013, 13:27-35.
92. Heemskerk D, Day J, Chau TT, et al. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials 2011, 12:25.
93. Schoeman J, Malan G, van Toorn R, Springer P, Parker F, Booysen J Home-based treatment of childhood neurotuberculosis. J Trop Pediatr 2009, 55:149-154.
94. Jacobs RF, Sunakorn P, Chotpitayasunonah T, Pope S, Kelleher K Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992, 11:194-198.
95. Woodfield J, Argent A Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?. J Trop Pediatr 2008, 54:220-224.
96. Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004, 42:996-1002.
97. Vinnard C, Winston CA, Wileyto EP, Macgregor RR, Bisson GP Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010, 341:c4451.
98. Guidelines for the pragmatic management of drug-resistant tuberculosis 2006, WHO, World Health Organization, Geneva.
99. Prasad K, Singh MB Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008, 1. CD002244.
100. Simmons CP, Thwaites GE, Quyen NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 2005, 175:579-590.
101. Tobin DM, Vary JC, Ray JP, et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010, 140:717-730.
102. Tobin DM, Roca FJ, Oh SF, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012, 148:434-446.
103. Schoeman JF, Andronikou S, Stefan DC, Freeman N, van Toorn R Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases. J Child Neurol 2010, 25:822-828.
104. Schoeman JF, Ravenscroft A, Hartzenberg HB Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess. Childs Nerv Syst 2001, 17:370-372.
105. Lee HS, Lee Y, Lee SO, et al. Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis. J Infect Chemother 2012, 18:555-557.
106. Misra UK, Kalita J, Nair PP Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010, 293:12-17.
107. Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P The role of aspirin in childhood tuberculous meningitis. J Child Neurol 2011, 26:956-962.
108. van Toorn R, Rabie H, Dramowski A, Schoeman JF Neurological manifestations of TB-IRIS: a report of 4 children. Eur J Paediatr Neurol 2012, 16:676-682.
109. Lee JY, Yim JJ, Yoon BW Adjuvant interferon-γ treatment in two cases of refractory tuberculosis of the brain. Clin Neurol Neurosurg 2012, 114:732-734.
110. Roca FJ, Ramakrishnan L TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013, 153:521-534.
111. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol 1995, 10:320-329.
112. Yaramis A, Gurkan F, Elevli M, et al. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 1998, 102:E49.
113. Schoeman JF, Laubscher JA, Donald PR Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits. Childs Nerv Syst 2000, 16:203-208.
114. Schoeman JF, le Roux D, Bezuidenhout PB, Donald PR Intracranial pressure monitoring in tuberculous meningitis: clinical and computerized tomographic correlation. Dev Med Child Neurol 1985, 27:644-654.
115. Figaji AA, Fieggen AG The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice. Tuberculosis (Edinb) 2010, 90:393-400.
116. Schoeman J, Donald P, van Zyl L, Keet M, Wait J Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol 1991, 33:396-405.
117. Bruwer GE, Van der Westhuizen S, Lombard CJ, Schoeman JF Can CT predict the level of CSF block in tuberculous hydrocephalus?. Childs Nerv Syst 2004, 20:183-187.
118. Lamprecht D, Schoeman J, Donald P, Hartzenberg H Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg 2001, 15:119-125.
119. Sifontes JE, Sordillo SV, Lincoln EM Pneumoencephalography in tuberculous meningitis. J Pediatr 1957, 50:695-707.
120. Bhagwati S, Mehta N, Shah S Use of endoscopic third ventriculostomy in hydrocephalus of tubercular origin. Childs Nerv Syst 2010, 26:1675-1682.
121. Figaji AA, Fieggen AG, Peter JC Endoscopy for tuberculous hydrocephalus. Childs Nerv Syst 2007, 23:79-84.
122. Misra UK, Kalita J, Prabhakar S, Chakravarty A, Kochar D, Nair PP Endoscopic third ventriculostomy in tuberculous meningitis needs more evidence. Ann Indian Acad Neurol 2012, 15:233.
123. Dastur DK, Lalitha VS, Udani PM, Parekh U The brain and meninges in tuberculous meningitis-gross pathology in 100 cases and pathogenesis. Neurol India 1970, 18:86-100.
124. Lammie GA, Hewlett RH, Schoeman JF, Donald PR Tuberculous cerebrovascular disease: a review. J Infect 2009, 59:156-166.
125. Schoeman J, Mansvelt E, Springer P, van Rensburg AJ, Carlini S, Fourie E Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Dis J 2007, 26:428-431.
126. Springer P, Swanevelder S, van Toorn R, van Rensburg AJ, Schoeman J Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis. Eur J Paediatr Neurol 2009, 13:343-349.
127. Sheu JJ, Hsu CY, Yuan RY, Yang CC Clinical characteristics and treatment delay of cerebral infarction in tuberculous meningitis. Intern Med J 2012, 42:294-300.
128. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997, 99:226-231.
129. Ravenscroft A, Schoeman JF, Donald PR Tuberculous granulomas in childhood tuberculous meningitis: radiological features and course. J Trop Pediatr 2001, 47:5-12.
130. Afghani B, Lieberman JM Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994, 19:1092-1099.
131. Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 2006, 21:301-308.
132. Török ME, Yen NT, Chau TT, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis. Clin Infect Dis 2011, 52:1374-1383.
133. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009, 48:e96-107.
134. Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013, 56:450-460.
135. Meintjes G, Scriven J, Marais S Management of the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep 2012, 9:238-250.